Merck As Anchor, Scale As Lever, Aurobindo Looks To Spar With Lonza, WuXi Group
Ryzneuta Licensed From Evive To Give Boost
Starting off with MSD as an anchor partner, Aurobindo plans to eventually spar with the likes of WuXi and Lonza while building scale for its biologics CDMO business. Meanwhile, EMA approval for a greenfield project in China and an US FDA nod for Ryzneuta, licensed from Yifan’s Evive Biotech, signal a boost.
